Although these are excellent models for studying tau pathology, they do not accurately recapitulate the state in early AD in which soluble, wild-type human tau is likely interacting with rising levels of oligomeric Aβ to confer synaptic toxicity. The gene discussed is MAPT; the disease is Alzheimer disease.